Industry expert's new report, “” provides in-depth data on BIOLASE’s industry position in the different medical equipment industry s it operates in. The report provides BIOLASE industry share information in One key industry categories – Dental Lasers. The report also provides data and data on the overall competitive landscape of the industry s, the industry player operates in. The report is supplemented with global corporate-level profile with data on the firm ’s business sectors, major products and services, competitors, locations and subsidiaries, financial deals and other key developments.

Scope of the Research

- Global industry player shares (in Revenues) information for the key industry s BIOLASE operates in – Dental Devices.
- BIOLASE’s industry player shares (in Revenues) information for all the key countries the industry player has presence in – United States, Canada, UK, Germany, France, Italy, Spain, Japan, China, India, and Australia.
- BIOLASE’s industry player shares (in Revenues) information for all the key industry categories the industry player has presence in – Dental Lasers.
- All the key data-points are for 2009 and cover all the key regions – North America, Europe, Asia Pacific (APAC), and Middle East and Africa (MEA).
- Global corporate-level profile with data on the firm ’s business sectors, major products and services, competitors, and locations and subsidiaries.
- Comprehensive coverage of the latest financial deals involving the industry player and its subsidiaries, if any – Mergers & Acquisitions (M&A), Asset Transactions, PE/VC, Equity Offerings, Debt Offerings, and Partnerships.

Why Should You Get This Report?

- Develop sales and industry ing strategies by identifying who-stands-where in the industry s, BIOLASE operates in.
- Plan your competition strategies by identifying the firm ’s shares in the industry s and geographic regions it operates in.
- Design your own inorganic growth and business-collaboration strategies by understanding the financial deals your competitors are involved in.
- Advance your understanding of the competitive landscape and the competitors by leveraging on the data and information provided in the report.
- Support your overall business strategies by leveraging on the key data and information provided in the report, which includes but not limited to BIOLASE’s industry positions.

Table Of Contents

1 Table of Contents 2
I. 1 List of Data tables 8
I. 2 List of Charts 9

II Introduction 10
II. 1 What Is This Report About? 10

III Definitions of March kets/Categories Covered 11
III. 1 Dental Devices 11
III. 1.1 Crowns and Bridges 11
III. 1.2 Dental Biomaterials 11
III. 1.3 Dental Chairs and Equipment 11
III. 1.4 Dental Implants 11
III. 1.5 Dental Lasers 11
III. 1.6 Dental Radiology Equipment 11

IV Company Snapshot 12
IV. 1 Key Information 12
IV. 2 Company Profile 12
IV. 3 Financial Performance 12
IV. 4 SWOT Snapshot 12
5 Business Overview 13
V. 1 Business Description 13
V. 2 Advanced Dental, Cosmetic and Surgical Lasers and Related Products 13
V. 2.1 Overview 13
V. 2.2 Financials 13
V. 2.3 March ket View 13
V. 2.4 Key Strategies 13
V. 3 Major Products and Services 14
V. 3.1 Overview 14

VI History 15

VII SWOT Analysis 18
VII. 1 Overview 18
VII. 2 BIOLASE Technology, Inc. Strengths 18
VII. 2.1 Proprietary Technology 18
VII. 2.2 Intellectual Property 19
VII. 2.3 Strengthened Alliance with Henry Schein 19
VII. 3 BIOLASE Technology, Inc. Weaknesses 19
VII. 3.1 Low Return on Equity 19
VII. 3.2 Geographically Concentrated Sales s 19
VII. 3.3 December lining March ket Share in Segment 20
VII. 3.4 Negative Operating March gin 20
VII. 3.5 Limited Liquidity Position 20
VII. 4 BIOLASE Technology, Inc. Opportunities 20
VII. 4.1 New Product Launches 20
VII. 4.2 Increasing Demand for Dental Services 20
VII. 4.3 March ket Growth in Emerging Economies 21
VII. 5 BIOLASE Technology, Inc. Threats 21
VII. 5.1 Rapid Technological Changes 21
VII. 5.2 Competitive Landscape 21
VII. 5.3 Stringent Government Regulations 21

VIII Competitors 22

IX Competitive Landscape 23
IX. 1 Dental Devices, Global, Market Shares (%), 2009 23

X BIOLASE Technology, Inc. Medical Equipment March ket Share Analysis 25
X. 1 BIOLASE Technology, Inc., Dental Devices, Global, March ket Share (2009) 25
X. 2 BIOLASE Technology, Inc., Asia-Pacific, March ket Share (2009) 26
X. 3 BIOLASE Technology, Inc., Europe, March ket Share (2009) 27
X. 4 BIOLASE Technology, Inc., North America, March ket Share (2009) 28

XI BIOLASE Technology, Inc. Medical Equipment March ket Share Analysis by Category 29
XI. 1 BIOLASE Technology, Inc., Dental Devices, Global, Category Sales Share (2009) 29
XI. 2 BIOLASE Technology, Inc., Asia-Pacific, Category Sales Share (2009) 30
XI. 2.1 BIOLASE Technology, Inc., Australia, Category Sales Share (2009) 30
XI. 3 BIOLASE Technology, Inc., Europe, Category Sales Share (2009) 31
XI. 3.1 BIOLASE Technology, Inc., France, Category Sales Share (2009) 31
XI. 3.2 BIOLASE Technology, Inc., Germany, Category Sales Share (2009) 31
XI. 3.3 BIOLASE Technology, Inc., Italy, Category Sales Share (2009) 32
XI. 3.4 BIOLASE Technology, Inc., Spain, Category Sales Share (2009) 32
XI. 3.5 BIOLASE Technology, Inc., United Kingdom, Category Sales Share (2009) 32
XI. 3.6 BIOLASE Technology, Inc., Other Europe, Category Sales Share (2009) 33
XI. 4 BIOLASE Technology, Inc., North America, Category Sales Share (2009) 34
XI. 4.1 BIOLASE Technology, Inc., Canada, Category Sales Share (2009) 34
XI. 4.2 BIOLASE Technology, Inc., United States, Category Sales Share (2009) 34
12 Key Executives 35

XIII Key Employee Biographies 36

XIV Company Statement 37
15 Operations and Subsidiaries 38
XV. 1 Headquarter 38
XV. 2 Other Locations and Subsidiaries 38

XVI Financial Deals Landscape 40
XVI. 1 BIOLASE Technology, Inc., Deals Volume Summary, from 2005 to 2010 40

XVII BIOLASE Technology, Inc., Merger and Acquisition Deal Summary By Region, from 2005 to 2010 41

XVIII BIOLASE Technology, Inc. Detailed Deal Summary 43
XVIII. 1 Partner agreements 43
XVIII. 1.1 BIOLASE Technology Enters Into Licensing Agreement With The Procter and Gamble Firms 43
XVIII. 1.2 BIOLASE Enters Into Distribution Agreements With Shanghai Haopu, E-Maxdent And Advanced Medical 44
XVIII. 2 Equity Offering 45
XVIII. 2.1 BIOLASE Technology Files Registration Statement For Public Offering Of US$ 9.5 Mln 45
XVIII. 2.2 BIOLASE Technology Completes Public Offering Of US$ 46.25 Mln 46

XIX Recent Developments 47
XIX. 1 Strategy And Business Planning 47
XIX. 1.1 March 05, 2009: BIOLASE Plans To Reduce Corporate Cost Structure 47
XIX. 1.2 December 02, 2008: BIOLASE Reduces Quarterly Fixed Costs By US$ 2 Mln 47
XIX. 2 Financial Announcements 47
XIX. 2.1 August 17, 2010: BIOLASE Reports Net Sales s Of US$ 5.89 Mln In Q2 2010 47
XIX. 2.2 March 18, 2010: BIOLASE Reports Net Sales Of US$ 43.3 Mln In 2009 48
XIX. 2.3 November 05, 2009: BIOLASE Reports Net Sales Of US$ 12 Mln In Q3 2009 49
XIX. 2.4 August 06, 2009: BIOLASE Posts US$ 2.3 Mln Net Income In Q2 2009 50
XIX. 2.5 July 07, 2009: BIOLASE Announces Preliminary Q2 2009 Results 51
XIX. 2.6 May 07, 2009: BIOLASE Posts US$ 4.7 Mln Net Loss In Q1 2009 51
XIX. 2.7 March 16, 2009: BIOLASE Reports 2008 Results 52
XIX. 2.8 February 05, 2009: BIOLASE Reports Preliminary 2008 Results 53
XIX. 2.9 November 05, 2008: BIOLASE Reports 3Q 2008 Results 53
XIX. 3 Corporate Communications 54
XIX. 3.1 October 18, 2010: BIOLASE Announces Compliance With Nasdaq Minimum Stockholders' Equity Requirement 54
XIX. 3.2 October 04, 2010: BIOLASE Promotes Dmitri Boutoussov To CTO 55
XIX. 3.3 September 30, 2010: BIOLASE Appointment Federico Pignatelli As CEO 55
XIX. 3.4 August 27, 2010: BIOLASE Names Federico Pignatelli As Executive Chairman 56
XIX. 3.5 August 24, 2010: BIOLASE Receives Deficiency Letter From NASDAQ 56
XIX. 3.6 July 19, 2010: BIOLASE Appoints Alex Arrow, Norman Nemoy To Board 56
XIX. 3.7 July 13, 2010: BIOLASE Eliminates 20 Positions 57
XIX. 3.8 July 13, 2010: BIOLASE Names Federico Pignatelli As Executive Vice Chairman 57
XIX. 3.9 July 13, 2010: BIOLASE Announces Resignation Of Brett Scott As CFO 58
XIX. 3.10 October 26, 2009: BIOLASE Appoints Gregory Waller To Its Board 58
XIX. 4 Legal and Regulatory 59
XIX. 4.1 May 19, 2010: Discus Dental, Zap Lasers Drop Allegation Of Fraud Against BIOLASE 59
XIX. 4.2 April 07, 2010: Discus Dental, Zap Lasers Files Lawsuit Against Biolase In California 59
XIX. 4.3 March 26, 2009: BIOLASE Reaches Settlement Agreement With NLT 60
XIX. 4.4 September 15, 2008: BIOLASE Files Counter Lawsuit Against NLT 60
XIX. 4.5 August 20, 2008: NLT Files Federal Lawsuit Against BIOLASE For Anticompetitive Conduct 61
XIX. 5 Product News 61
XIX. 5.1 June 11, 2010: BIOLASE Receives Canadian Approval For iLase Personal Dental Laser System 61
XIX. 5.2 April 14, 2010: BIOLASE Wins US Patent For ezlase And iLase Diode Lasers 61
XIX. 5.3 April 06, 2010: BIOLASE To Present Water-Based Laser Technology For Eye Surgery At American Society Of Cataract And Refractive Surgery Symposium And Congress 62
XIX. 5.4 March 16, 2010: BIOLASE Receives FDA 510(K) Approval For iLase Personal Laser 62
XIX. 5.5 February 25, 2010: BIOLASE Introduces iLase Personal Laser For Dental 63
XIX. 5.6 February 22, 2010: BIOLASE To Unveil New Dental Laser At Chicago Midwinter Dental Show 64
XIX. 5.7 December 09, 2009: BIOLASE Receives FDA 510(K) Approval For Waterlase MD Laser To Treat Periodontitis 64
XIX. 5.8 November 03, 2009: BIOLASE Technology Launches Diolase 10 Diode Laser For Therapeutic Applications 65
XIX. 5.9 April 16, 2009: BIOLASE Technology Receives FDA 510(k) Clearance For Its ezlase Diode Laser For Pain Therapy and Relief 66
XIX. 6 Product Approvals 67
XIX. 6.1 June 11, 2010: BIOLASE Receives Canadian Approval For iLase Personal Dental Laser System 67
XIX. 6.2 December 09, 2009: BIOLASE Receives FDA 510(K) Approval For Waterlase MD Laser To Treat Periodontitis 67
XIX. 6.3 April 16, 2009: BIOLASE Technology Receives FDA 510(k) Clearance For Its ezlase Diode Laser For Pain Therapy and Relief 68
XIX. 6.4 March 19, 2008: BIOLASE Announces FDA 510(k) Clearance Of Waterlase MD Laser System For Root Canal Disinfection 69
XIX. 7 Other Significant Developments 69
XIX. 7.1 September 30, 2010: BIOLASE Announces 30% Increase In Sales Force 69
XIX. 7.2 September 27, 2010: BIOLASE Announces Extensive Restructuring 70
XIX. 7.3 September 27, 2010: BIOLASE Announces Non-Exclusive Distribution Agreement With Henry Schein 70
XIX. 7.4 March 10, 2010: BIOLASE And Henry Schein Extend And Amend Licensing And Distribution Agreement 71
XIX. 7.5 September 28, 2009: BIOLASE Announces Distribution Agreements In China 71
XIX. 7.6 March 05, 2009: BIOLASE Renew Distribution Agreement With Henry Schein 72
XIX. 7.7 February 05, 2009: BIOLASE Reveals Operational Restructuring 72
XIX. 7.8 March 07, 2008: BIOLASE And Henry Schein Renew Distribution Agreement 73

XX Appendix 74
XX. 1 Research Methodology 75
XX. 2 Secondary Research 75
XX. 3 Primary Research 76
XX. 4 Models 76
XX. 5 Forecasted data s 76
XX. 6 Expert Panels 77
XX. 7 GlobalData Consulting 77
XX. 8 Currency Conversion 78
XX. 9 Contact Us 79
XX. 10 Disclaimer 79

1.1 List of Data tables
Data table 1: BIOLASE Technology, Inc., Major development, 2009 12
Data table 2: BIOLASE Technology, Inc., SWOT Analysis, 2009 18
Data table 3: Dental Devices, Global, Market Shares by Sales (USD Million), 2009 24
Data table 4: BIOLASE Technology, Inc., Dental Devices, Global, Sales (USD Million) and March ket Share (%), 2009 25
Data table 5: BIOLASE Technology, Inc., Dental Devices, Asia-Pacific, Sales (USD Million) and March ket Share (%), 2009 26
Data table 6: BIOLASE Technology, Inc., Dental Devices, Europe, Sales (USD Million) and March ket Share (%), 2009 27
Data table 7: BIOLASE Technology, Inc., Dental Devices, North America, Sales (USD Million) and March ket Share (%), 2009 28
Data table 8: BIOLASE Technology, Inc., Dental Devices, Global, Sales (USD Million) and March ket Share (%) by Category, 2009 29
Data table 9: BIOLASE Technology, Inc., Dental Devices, Asia-Pacific, Sales (USD Million) and March ket Share (%) by Category, 2009 30
Data table 10: BIOLASE Technology, Inc., Dental Devices, Australia, Sales (USD Million) and March ket Share (%) by Category, 2009 30
Data table 11: BIOLASE Technology, Inc., Dental Devices, Europe, Sales (USD Million) and March ket Share (%) by Category, 2009 31
Data table 12: BIOLASE Technology, Inc., Dental Devices, France, Sales (USD Million) and March ket Share (%) by Category, 2009 31
Data table 13: BIOLASE Technology, Inc., Dental Devices, Germany, Sales (USD Million) and March ket Share (%) by Category, 2009 31
Data table 14: BIOLASE Technology, Inc., Dental Devices, Italy, Sales (USD Million) and March ket Share (%) by Category, 2009 32
Data table 15: BIOLASE Technology, Inc., Dental Devices, Spain, Sales (USD Million) and March ket Share (%) by Category, 2009 32
Data table 16: BIOLASE Technology, Inc., Dental Devices, United Kingdom, Sales (USD Million) and March ket Share (%) by Category, 2009 32
Data table 17: BIOLASE Technology, Inc., Dental Devices, Other Europe, Sales (USD Million) and March ket Share (%) by Category, 2009 33
Data table 18: BIOLASE Technology, Inc., Dental Devices, North America, Sales (USD Million) and March ket Share (%) by Category, 2009 34
Data table 19: BIOLASE Technology, Inc., Dental Devices, Canada, Sales (USD Million) and March ket Share (%) by Category, 2009 34
Data table 20: BIOLASE Technology, Inc., Dental Devices, United States, Sales (USD Million) and March ket Share (%) by Category, 2009 34
Data table 21: BIOLASE Technology, Inc., Key Executives 35
Data table 22: BIOLASE Technology, Inc., Other Locations 38
Data table 23: BIOLASE Technology, Inc., Subsidiaries 39
Data table 24: BIOLASE Technology, Inc., Deals Volume Summary, from 2005 to 2010 40
Data table 25: BIOLASE Technology, Inc., Merger and Acquisition Deal Summary By Region, from 2005 to 2010 41
Data table 26: BIOLASE Technology, Inc., Merger and Acquisition Deal Summary, from 2005 to 2010 42
Data table 27: BIOLASE Technology Enters Into Licensing Agreement With The Procter and Gamble Firms 43
Data table 28: BIOLASE Enters Into Distribution Agreements With Shanghai Haopu, E-Maxdent And Advanced Medical 44
Data table 29: BIOLASE Technology Files Registration Statement For Public Offering Of US$ 9.5 Mln 45
Data table 30: BIOLASE Technology Completes Public Offering Of US$ 46.25 Mln 46
Data table 31: US Dollar to Local Currency, Average Exchange Rate 2009 78

1.2 List of Charts
Chart 1: Dental Devices, Global, Market Shares (%), 2009 23
Chart 2: BIOLASE Technology, Inc., Dental Devices, Global, March ket Share (%), 2009 25
Chart 3: BIOLASE Technology, Inc., Dental Devices, Europe, March ket Share (%), 2009 27
Chart 4: BIOLASE Technology, Inc., Dental Devices, North America, March ket Share (%), 2009 28
Chart 5: BIOLASE Technology, Inc., Deals Volume Summary, from 2005 to 2010 40
Chart 6: BIOLASE Technology, Inc., Merger and Acquisition Deal Summary By Region, from 2005 to 2010 41

Companies mentionedThe following industry players are the major competitors of BIOLASE Technology, Inc.:

3M ESPE Dental Products
A-dec Inc.
Astra Tech AB
BIOMET 3i, Inc.
Carestream Health, Inc. / Kodak Health Group
DENTSPLY International Inc.
Discus Dental, LLC
Geistlich Pharma AG
Gendex Dental Systems
HOYA ConBio
Instrumentarium Dental
Ivoclar Vivadent AG
J. Morita USA, Inc.
KaVo Dental Corporation
Lares Research
Nobel Biocare Holding AG
Osada Electric Firms, Limited.
OSSTEM IMPLANT Co., Ltd.
Pelton and Crane Firms
Planmeca Oy
Sirona Dental Systems, Inc.
Straumann Holding AG
Syneron Medical Ltd.
Takara Belmont Corporation
Yoshida Dental Mfg. Co.,Ltd.
Zimmer Holdings, Inc.

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

KaVo Dental GmbH SWOT Analysis, Strategy, Revenues and Profits

KaVo Dental GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • November 2014
  • by Global Data

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...

Nobel Biocare Holding AG (Symbol:NOBN) SWOT Analysis, Strategy, Revenues and Profits

Nobel Biocare Holding AG (Symbol:NOBN) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • July 2014
  • by Global Data

Nobel Biocare Holding AG (Nobel Biocare) is a medical devices company engaged in the production of pioneering dental solutions. The company provides advanced science-based solutions from root to tooth, ...

Nakanishi Inc. (Symbol:7716) SWOT Analysis, Strategy, Revenues and Profits

Nakanishi Inc. (Symbol:7716) SWOT Analysis, Strategy, Revenues and Profits

  • $ 125
  • Company report
  • June 2014
  • by Global Data

Nakanishi Inc. (Nakanishi) is engaged in the design, development, manufacture and marketing of high quality and high cost performance products for the fields of dentistry, surgery and general industrial. ...


ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.